Select Region
Search
Contact
|
FAQs
Home
Product Details
Media
News
Events
Clinical Resources
Events
Product Details
News
User Comments
HAI Watch
Articles and Resources
Product Literature:
--Select--
Brochure
Catalog Sheet
Demo Card
Select Language:
--Select--
English
Spanish
Portuguese
French
German
Finnish
Swedish
Dutch/Flemish
Japanese
Technical Literature:
--Select--
Abstract
Performance Summary
Report
Testimonials
Select Language:
--Select--
English
Spanish
Portuguese
French
German
Finnish
Swedish
Dutch/Flemish
Japanese
Search Article Reprints
Search Resource Links
Articles & Reprints
Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study
The attributable impact of S. aureus and methicillin-resistance on outcomes of surgical patients is substantial. Preventing a single case of SSI due to MRSA can save hospitals as much as $60,000.
Guideline for Prevention of Surgical Site Infection, 1999
Alicia J. Mangram, MD; Teresa C. Horan, MPH, CIC; Michele L. Pearson, MD; Leah Christine Silver, BS; William R. Jarvis, MD; The Hospital Infection Control Practices Advisory Committee, Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention Public Health Service, US Department of Health and Human Services
Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge
Eli N. Perencevich,*† Kenneth E. Sands,*† Sara E. Cosgrove,* Edward Guadagnoli,‡ Ellen Meara,‡ and Richard Platt§†‡, *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; †Centers for Disease Control and Prevention Eastern Massachusetts Prevention Epicenter, Boston, MA, USA; ‡Harvard Medical School, Boston, MA, USA; and §Brigham and Women’s Hospital, Boston, MA, USA
Non Pharmaceutical Methods to Reduce SSIs
The European Symposium at the Society of Surgical Infection Congress examines some of the non-pharmaceutical strategies used in the fight against SSIs.
Risk Factors for Surgical Site Infection After Low Transverse Cesarean Section
Independent risk factors for surgical site infection (SSI) after cesarean section have not been well documented, despite the large number of cesarean sections performed and the relatively common occurrence of SSI. Objective. To determine independent risk factors for SSI after low transverse cesarean section. Design. Retrospective case-control study. setting. Barnes-Jewish Hospital, a 1,250-bed tertiary care hospital.
Roundtable Discussion: New Opportunities for Reducing Risk of Surgical Site Infection
“Roundtable Discussion: New Opportunities for Reducing Risk of Surgical Site Infection,” Surgical Infections, Spring 2006. Official Journal of the Surgical Infection Society—Europe.
Significant Reduction in Incidence of Wound Contamination by Skin Flora
Shirin Towfigh, MD; William G. Cheadle, MD; Stephen F. Lowry, MD; Mark A. Malangoni, MD; Samuel E. Wilson, MD Arch Surg. 2008;143(9):885-891
Resource Links
Emerging Infectious Diseases Journal, US Centers for Disease Control & Prevention
European Association for Cardio-Thoracic Surgery
European Hospitals Online
European Society of Cardiovascular Surgery
Infection Prevention Society (UK)
NHS Clean, Safe Care Site (UK)
Reducing C-Section infections
Safer Healthcare Now! Campaign, Canadian Patient Safety Institute
Stop Sports Infections website
Surgical Infection Society
Surgical Infection Society - Europe
US Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion
Product Literature
Brochure-DE InteguSeal* Technisches Daten-Dokument
Brochure-FI: InteguSeal* Tekniset tiedot Asiakirja
Brochure-FR - InteguSeal* document technique de données
Brochure-NL InteguSeal* Het technische Document van Gegevens
Brochure-SV InteguSeal* Tekniskt datadokument
Catalog Sheet-EN - InteguSeal US Tech Data Sell Sheet
DE-Brochure
De-Demo Card
EN-Brochure: InteguSeal Cost-Benefit Brochure (US)
EN-Brochure: InteguSeal Tech Data Brochure (UK)
EN-Brochure: InteguSeal* Sales Brochure (UK)
EN-Brochure: InteguSeal* Sales Brochure (US)
EN-Demo Card
FI-Brochure
FI-Demo Card
FR-Brochure
FR-Demo Card
NL-Brochure
NL-Demo Card
SV-Brochure
SV-Demo Card
Technical Literature
DE-Abstract: Can we prevent surgical site infections during cardiac surgery by additional use of a microbial sealant?
DE-Abstract: Dohmen Preliminary Study
DE-Performance Summary
EN: Iceland Symposium Report: New non-pharmaceutical ways to reduce surgical site infections, June 2007
EN-Abstract: Can we prevent surgical site infections during cardiac surgery by additional use of a microbial sealant?
EN-Abstract: Dohmen Preliminary Study
EN-Performance Summary
EN-Report: International Symposium on New Non-Pharmaceutical Ways to Reduce Surgical Site Infections
EN-Testimonials: Clinical Testimonials on Pathogen Control and Temperature Management
FI-Performance Summary
FR-Abstract: Can we prevent surgical site infections during cardiac surgery by additional use of a microbial sealant?
FR-Abstract: Dohmen Preliminary Study
FR-Performance Summary
NL-Abstract: Can we prevent surgical site infections during cardiac surgery by additional use of a microbial sealant?
NL-Abstract: Dohmen Preliminary Study
NL-Performance Summary
SV-Performance Summary
Copyright 2008 Kimberly-Clark Worldwide, Inc. All Rights Reserved.
Your visit to this site and use of the information hereon is subject to the terms of our
Legal Statement
. Please Review our
Privacy Statement
.
*Registered Trademark or Trademark of Kimberly-Clark Worldwide, Inc., or its affiliates